These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31069228)

  • 1. Geospatial Correlation of Amyopathic Dermatomyositis With Fixed Sources of Airborne Pollution: A Retrospective Cohort Study.
    Pearson DR; Werth VP
    Front Med (Lausanne); 2019; 6():85. PubMed ID: 31069228
    [No Abstract]   [Full Text] [Related]  

  • 2. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
    Mukae H; Ishimoto H; Sakamoto N; Hara S; Kakugawa T; Nakayama S; Ishimatsu Y; Kawakami A; Eguchi K; Kohno S
    Chest; 2009 Nov; 136(5):1341-1347. PubMed ID: 19581351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort.
    Galimberti F; Li Y; Fernandez AP
    Br J Dermatol; 2016 Jan; 174(1):158-64. PubMed ID: 26490490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically amyopathic dermatomyositis: analysis of a monocentric cohort.
    Neri R; Barsotti S; Iacopetti V; Tripoli A; dʼAscanio A; Tavoni AG; Mosca M; Bombardieri S
    J Clin Neuromuscul Dis; 2014 Jun; 15(4):157-60. PubMed ID: 24872214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
    Ikeda S; Arita M; Misaki K; Mishima S; Takaiwa T; Nishiyama A; Ito A; Furuta K; Yokoyama T; Tokioka F; Noyama M; Yoshioka H; Ishida T
    Springerplus; 2015; 4():240. PubMed ID: 26101728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis.
    Sontheimer RD
    Ann Transl Med; 2017 Apr; 5(7):160. PubMed ID: 28480196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and risk factors associated with interstitial lung disease in patients with classic dermatomyositis or clinical amyopathic dermatomyositis].
    Lin H; Liang Y; Wang Y; Cen XM; Yin G; Xie QB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):805-9. PubMed ID: 24325117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geospatial patterns in influenza vaccination: evidence from uninsured and publicly insured children in North Carolina.
    Trogdon JG; Ahn T
    Am J Infect Control; 2015 Mar; 43(3):234-40. PubMed ID: 25637432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial Patterns and Determinants of Diabetes Mellitus in Indian Adult Population: a Secondary Data Analysis from Nationally Representative Surveys.
    Krishnamoorthy Y; Rajaa S; Verma M; Kakkar R; Kalra S
    Diabetes Ther; 2023 Jan; 14(1):63-75. PubMed ID: 36329233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personal and ambient exposures to air toxics in Camden, New Jersey.
    Lioy PJ; Fan Z; Zhang J; Georgopoulos P; Wang SW; Ohman-Strickland P; Wu X; Zhu X; Harrington J; Tang X; Meng Q; Jung KH; Kwon J; Hernandez M; Bonnano L; Held J; Neal J;
    Res Rep Health Eff Inst; 2011 Aug; (160):3-127; discussion 129-51. PubMed ID: 22097188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis.
    Chen M; Quan C; Diao L; Xue F; Xue K; Wang B; Li X; Zhu X; Zheng J; Cao H
    Br J Dermatol; 2018 Dec; 179(6):1334-1341. PubMed ID: 30101523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geospatial patterns in human papillomavirus vaccination uptake: evidence from uninsured and publicly insured children in North Carolina.
    Trogdon JG; Ahn T
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):595-602. PubMed ID: 25576528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
    Horiike Y; Suzuki Y; Fujisawa T; Yasui H; Karayama M; Hozumi H; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Ogawa N; Suda T
    Rheumatology (Oxford); 2019 Dec; 58(12):2143-2152. PubMed ID: 31143953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease.
    Sato S; Kuwana M; Fujita T; Suzuki Y
    Mod Rheumatol; 2013 May; 23(3):496-502. PubMed ID: 22644102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
    Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.